D'Souza, M P <br/><br/>
Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: performance criteria for selecting candidate antibodies for clinical trials. AIDS Clinical Trials Group Antibody Selection Working Group.  [electronic resource] 

 -  The Journal of infectious diseases  May 1997 
 - 1056-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-1899 
<br/><br/><label>Standard No.: </label>10.1086/516443  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acquired Immunodeficiency Syndrome--blood<br/>Adult<br/>Amino Acid Sequence<br/>Antibodies, Monoclonal--blood<br/>Antibody Specificity<br/>Antigens, CD--physiology<br/>CD4 Antigens--physiology<br/>Child<br/>Clinical Trials as Topic--methods<br/>Epitopes--analysis<br/>HIV Antibodies--blood<br/>HIV Envelope Protein gp160--chemistry<br/>HIV Envelope Protein gp41--chemistry<br/>HIV Seropositivity--blood<br/>HIV-1--classification<br/>Humans<br/>Immunoglobulin G--blood<br/>Molecular Sequence Data<br/>Neutralization Tests--standards<br/>Sensitivity and Specificity